Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Novel polyspecific antibody-agent conjugates from Immunomedics

Jan. 16, 1998

Dysentery vaccine technology available for licensing from NIH

Jan. 15, 1998

Vertex describes new IMPDH inhibitors

Jan. 14, 1998

Novel thalidomide prodrugs reported in patent literature

Jan. 12, 1998

ABX-CBL evaluated in phase II GVHD trial

Jan. 7, 1998

New immunosuppressants in the pipeline at Merck & Co.

Dec. 31, 1997

MedImmune and BioTransplant plan to test MEDI-507 for graft-vs.-host disease

Dec. 29, 1997

CY-1503 reduces reperfusion injury in a dog lung allograft model

Dec. 22, 1997

In vitro and in vivo immunosuppressive effects of FTY-720

Dec. 22, 1997

HHS announces intention to out-license vaccine technology

Dec. 19, 1997

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...